|
Comparison of Airway Management With Bronchial Blocker and Double-Lumen Tube in Single-Lung Ventilation
RECRUITINGN/ASponsored by Ankara City Hospital Bilkent
Actively Recruiting
PhaseN/A
SponsorAnkara City Hospital Bilkent
Started2024-02-01
Est. completion2024-08-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06299735
Summary
In this study, the primary aim is to compare the impact of using a double-lumen tube and bronchial blocker for single-lung ventilation in patients undergoing minimal invasive cardiac surgeries on postoperative pulmonary functions. Secondary objectives include the comparison of application duration, success in lung collapse, and the number of repositioning attempts for both techniques.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Patients planned for on-pump minimal invasive cardiac surgical procedures requiring single-lung ventilation * Female and male patients aged 18 and above * Patients with ASA scores of 1-2-3 * Patients with signed informed consent to participate in the study * Patients with a Body Mass Index (BMI) less than 40 Exclusion Criteria: * Emergency surgeries * Patients with ASA scores greater than 3 * Advanced-stage organ (heart, kidney, liver, lung) failure * Advanced lung diseases (COPD, FEV1\<50%, restrictive lung diseases, history of chest surgery, Pulmonary Hypertension, PAB\>30mmHg) * Patients with anticipated difficult intubation * Pregnant individuals * Patients with a BMI greater than 40 * Patients lacking the ability to read, understand, sign the informed consent form, and those who do not wish to participate in the study
Conditions4
Coronary ArteriosclerosisHeart DiseaseHeart Valvular DiseaseOne-lung Ventilation
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorAnkara City Hospital Bilkent
Started2024-02-01
Est. completion2024-08-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06299735